Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex

Author:

Loiseau Chloé12,Brites Daniela12,Moser Irmgard3,Coll Francesc4,Pourcel Christine5,Robbe-Austerman Suelee6,Escuyer Vincent7,Musser Kimberlee A.7,Peacock Sharon J.8,Feuerriegel Silke910,Kohl Thomas A.910,Niemann Stefan910,Gagneux Sebastien12,Köser Claudio U.11ORCID

Affiliation:

1. Swiss Tropical and Public Health Institute, Basel, Switzerland

2. University of Basel, Basel, Switzerland

3. Friedrich-Loeffler-Institut, Federal Institute for Animal Health, Institute of Molecular Pathogenesis, Jena, Germany

4. Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

5. Institute for Integrative Biology of the Cell, Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France

6. National Veterinary Services Laboratories, United States Department of Agriculture, Ames, Iowa, USA

7. Wadsworth Center, New York State Department of Health, Albany, New York, USA

8. Department of Medicine, University of Cambridge, Cambridge, United Kingdom

9. Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany

10. German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Germany

11. Department of Genetics, University of Cambridge, Cambridge, United Kingdom

Abstract

Using 894 phylogenetically diverse genomes of the Mycobacterium tuberculosis complex (MTBC), we simulated in silico the ability of the Hain Lifescience GenoType MTBC assay to differentiate the causative agents of tuberculosis. Here, we propose a revised interpretation of this assay to reflect its strengths (e.g., it can distinguish some strains of Mycobacterium canettii and variants of Mycobacterium bovis that are not intrinsically resistant to pyrazinamide) and limitations (e.g., Mycobacterium orygis cannot be differentiated from Mycobacterium africanum ).

Funder

Wellcome Trust

Swiss National Science Foundation

EC | European Research Council

Deutsche Forschungsgemeinschaft

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference28 articles.

1. Evaluation of Genotype MTBC Assay for Differentiation of Clinical Mycobacterium tuberculosis Complex Isolates

2. Clinical and Laboratory Standards Institute. Laboratory detection and identification of mycobacteria, 2nd edition. CLSI document M48. Clinical and Laboratory Standards Institute, Wayne, PA.

3. Ecology and evolution of Mycobacterium tuberculosis

4. Importance of the Genetic Diversity within the Mycobacterium tuberculosis Complex for the Development of Novel Antibiotics and Diagnostic Tests of Drug Resistance

5. Hain Lifescience GmbH. 2017. GenoType MTBC VER 1.X. Instructions for use IFU-301-11. Hain Lifescience GmbH Nehren Germany.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3